Gliosarcoma: A Multi-Institutional Analysis on Clinical Outcomes and Prognostic Factors.

Autor: Roohani S; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; BIH Charité Junior Clinician Scientist Program, Berlin Institute of Health at Charité-Universitätsmedizin Berlin, BIH Biomedical Innovation Academy, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Germany, Heidelberg, Germany., Mirwald M; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Ehret F; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Germany, Heidelberg, Germany., Fink C; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; National Center of Radiation Oncology, Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., König L; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.; National Center of Radiation Oncology, Heidelberg Institute of Radiation Oncology (HIRO), Heidelberg, Germany.; National Center for Tumor Diseases (NCT), Heidelberg, Germany., Striefler JK; Department of Internal Medicine II, Oncology/Hematology/BMT/Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Jacob NS; Department of Internal Medicine II, Oncology/Hematology/BMT/Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Popp I; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, Freiburg, Germany.; German Cancer Consortium (DKTK) Partner Site Freiburg, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany., Steffel J; Department of Radiation Oncology, Medical Center University of Freiburg, Faculty of Medicine, Freiburg, Germany., Handtke J; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Claßen NM; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Rotermund T; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Zips D; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Germany, Heidelberg, Germany., Vajkoczy P; Department of Neurosurgery, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany., Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Spałek MJ; Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.; Department of Radiotherapy I, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Kaul D; Department of Radiation Oncology, Charité-Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.; German Cancer Consortium (DKTK), partner site Berlin, a partnership between DKFZ and Charité-Universitätsmedizin Berlin, Germany, Heidelberg, Germany.

Publikováno v: Cancer medicine [Cancer Med] 2024 Nov; Vol. 13 (22), pp. e70347.

The Role of Fibroblast Activation Protein in Glioblastoma and Gliosarcoma: A Comparison of Tissue, ⁶⁸ Ga-FAPI-46 PET Data, and Survival Data.

Autor: Oster C; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site Essen-Düsseldorf, Partnership Between DKFZ and University Hospital Essen, Essen, Germany; and DKFZ-Division of Translational Neurooncology at West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany., Kessler L; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and National Center for Tumor Diseases (NCT), NCT West, Essen, Germany., Blau T; Institute of Neuropathology, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Keyvani K; Institute of Neuropathology, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Pabst KM; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and National Center for Tumor Diseases (NCT), NCT West, Essen, Germany., Fendler WP; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and National Center for Tumor Diseases (NCT), NCT West, Essen, Germany., Fragoso Costa P; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and National Center for Tumor Diseases (NCT), NCT West, Essen, Germany., Lazaridis L; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Schmidt T; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Feldheim J; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Pierscianek D; Department of Neurosurgery and Spine Surgery, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany.; Department of Neurosurgery and Spine Surgery, St. Marienhospital Lünen, Lünen, Germany., Schildhaus HU; Institute of Pathology, University Medicine Essen, University Duisburg-Essen, Essen, Germany.; Discovery Life Sciences Biomarker Services GmbH, Kassel, Germany., Sure U; Department of Neurosurgery and Spine Surgery, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany., Ahmadipour Y; Department of Neurosurgery and Spine Surgery, Center for Translational Neuro- and Behavioral Sciences (C-TNBS), University Medicine Essen, University Duisburg-Essen, Essen, Germany., Kleinschnitz C; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Guberina N; Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Stuschke M; Department of Radiotherapy, University Medicine Essen, University Duisburg-Essen, Essen, Germany., Deuschl C; Institute for Diagnostic and Interventional Radiology and Neuroradiology, University Medicine Essen, University of Duisburg-Essen, Essen, Germany., Scheffler B; German Cancer Consortium (DKTK), Partner Site Essen-Düsseldorf, Partnership Between DKFZ and University Hospital Essen, Essen, Germany; and DKFZ-Division of Translational Neurooncology at West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany; and., Herrmann K; Department of Nuclear Medicine, University of Duisburg-Essen, and German Cancer Consortium (DKTK)-University Hospital Essen, Essen, Germany; and National Center for Tumor Diseases (NCT), NCT West, Essen, Germany.; National Center for Tumor Diseases (NCT), NCT West, Heidelberg, Germany., Kebir S; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK), Partner Site Essen-Düsseldorf, Partnership Between DKFZ and University Hospital Essen, Essen, Germany; and DKFZ-Division of Translational Neurooncology at West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany., Glas M; Department of Neurology and Center for Translational Neuro- and Behavioral Sciences (C-TNBS), Division of Clinical Neurooncology, University Medicine Essen, University Duisburg-Essen, Essen, Germany; martin.glas@uk-essen.de.; German Cancer Consortium (DKTK), Partner Site Essen-Düsseldorf, Partnership Between DKFZ and University Hospital Essen, Essen, Germany; and DKFZ-Division of Translational Neurooncology at West German Cancer Center (WTZ), University Medicine Essen, University Duisburg-Essen, Essen, Germany.

Publikováno v: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2024 Aug 01; Vol. 65 (8), pp. 1217-1223. Date of Electronic Publication: 2024 Aug 01.

Competing Risk Model to Determine the Prognostic Factors for Patients with Gliosarcoma.

Autor: Chen M; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China; Clinical Neuroscience Institute, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Huang L; Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Wang F; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China; Clinical Neuroscience Institute, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Xu X; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China; Clinical Neuroscience Institute, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China., Xu X; Department of Neurology and Stroke Center, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China; Clinical Neuroscience Institute, The First Affiliated Hospital of Jinan University, Guangzhou, Guangdong, China. Electronic address: xiaohongxu86@jnu.edu.cn.

Publikováno v: World neurosurgery [World Neurosurg] 2024 Mar; Vol. 183, pp. e483-e494. Date of Electronic Publication: 2023 Dec 27.

Transformation of IDH-wildtype glioblastoma to gliosarcoma with features of osteosarcoma.

Autor: Sobczyk P; Department of Neurosurgery, Institute of Psychiatry and Neurology, Warsaw, Poland., Sobstyl M; Department of Neurosurgery, Institute of Psychiatry and Neurology, Warsaw, Poland., Acewicz A; Department of Neuropathology, Institute of Psychiatry and Neurology, Warsaw, Poland., Rosa J; Department of Pathomorphology, Independent Public Clinical Hospital No. 2 PUM, Szczecin, Poland., Grabiec M; Department of Translational Immunology and Experimental Intensive Care, Centre of Postgraduate Medical Education, Warsaw, Poland., Grajkowska W; Department of Pathomorphology, Center of Postgraduate Medical Education, Warsaw, Poland.

Publikováno v: Folia neuropathologica [Folia Neuropathol] 2024; Vol. 62 (1), pp. 96-101.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.